GEHC Chart

1 Month

	Date	Diff
	2023-03-28	+0.68 %
Global veterinary diagnostic imaging market size is expected to reach USD 3.15 billion by 2030, attributed to growing animal health expenditures, increasing disease control and disease prevention measures, according to Spherical Insights & Consulting, and this growth may have caused the 0.68% uptick in GE Healthcare (GEHC) stock. Global Veterinary Diagnostic Imaging Market is expected to grow from USD 1.90 billion in 2021 to USD 3.15 Billion by 2030, with GE Healthcare (GEHC) as one of the companies expected to benefit from the growing demand for veterinary diagnostic imaging equipment due to its diverse and advanced product portfolio.
	2023-03-27	-0.1 %
The article is not about GE Healthcare stock; it is about a new software package, PALMO, designed to analyze longitudinal bulk and single-cell omics data, and its performance in analyzing a multi-omics dataset of five data modalities on the same samples; therefore, it does not provide an explanation for why GE Healthcare stock has gone down.
	2023-03-24	+0.99 %
The article does not discuss GE Healthcare (GEHC) stock, therefore there is no information on why it may have gone up. GE Healthcare's stock went up by 0.99% after the company announced the development of TriSb92, a trimeric antibody-mimetic sherpabody that targets a conserved region of the viral spike glycoprotein and is highly manufacturable, stable, and resistant against viral sequence evolution, with the potential to be used as a nasal spray for protecting susceptible individuals from SARS-CoV-2 infection. GE Healthcare Technologies stock went up 0.99% due to the company's expected mid-single-digit percentage revenue growth and margin expansion, which is expected to result in a 300 to 500 basis points growth in operating margin over the medium term. The company is ideally positioned to grow in precision healthcare with its imaging equipment and imaging agents used to diagnose patients and precisely target drug delivery, and its potential to regain its market position lost in 2022 further contributes to the possibility of ramping up its margins and profitability in the coming years.
	2023-03-23	+1.26 %
GE Healthcare (GEHC) stock went up by 1.26% last night, but the article itself is about XVIVO Perfusion AB's upcoming Annual General Meeting, with proposed agenda items including the election of a Chairman, election of Board members, determination of fees for the Board of Directors and the auditor, and proposals to change the articles of association and adopt a long-term incentive programme for senior executives and key individuals in the XVIVO group.
	2023-03-22	-2.29 %
GE Healthcare (GEHC) stock was down by 2.29% last night, however, the article is not related to the stock market but rather it discusses a scientific investigation into the circadian clock of the primitive bacteria Rhodobacter sphaeroides which may shed light on the evolution of self-sustained oscillators.
	2023-03-20	-0.84 %
GE Healthcare's stock (GEHC) was down 0.84% last night, following InfuSystem Holdings' underperformance against expectations for the end of 2022, resulting from material deals that did not develop as expected at year-end, along with operational and supply chain issues.
	2023-03-15	-0.49 %
During GE's Investor Conference, GE Healthcare reaffirmed its 2023 guidance, which includes high-single-digit organic revenue growth, adjusted EPS of $1.60 to $2.00, and free cash flow of $3.4 billion to $4.2 billion; however, GEHC stock was down 0.49% last night likely due to broader market concerns and not specific to the company's performance. GE Healthcare (GEHC) stock went down by 0.49% as a result of Larry Culp's efforts to clean up the mess Welch left after playing earnings and accounting games, leading to a reversal of Welch's heritage as the company is now being dismantled. GE Healthcare (GEHC) stock went down because the company's profitability was impacted by higher costs despite its revenue increasing by 4.3% year-over-year and acquisitions such as Imactis and Caption Health. GE Healthcare (GEHC) stock was down -0.49% last night, possibly due to a research article linking trichloroethylene, a widely-used industrial solvent and common environmental contaminant, to Parkinson's disease, which calls for further research, protection, and remediation of its contamination.
	2023-03-13	+1.69 %
GE Healthcare (GEHC) stock went up 1.69% after Evercore gave the company a bullish rating following its recent spinoff from General Electric. GE Healthcare (GEHC) stock went up 1.69% after Evercore ISI analyst Vijay Kumar initiated coverage of the company with a Buy rating and $90 price target.